In an article published in Gene Therapy (Vol. 13, pp. 1133–1142), a group of scientists, led by Dr. R. Laguens, conclude that plasmid-mediated VEGF gene transfer reduces myocardial infarct size by a combination of effects including neovascular proliferation, modification of fibrosis and cardiomyocyte regeneration.
Dr. R. Laguens, Department of Pathology, Favaloro University, Solís 453 (1078) Buenos Aires, Argentina.
Abstract available online.
(C) Gene Therapy.
Posted by: Tressie Dalaya
Message posted by: Trevor M. D'Souza